Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis
- PMID: 38440228
- PMCID: PMC10910229
- DOI: 10.3389/fonc.2024.1383366
Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis
Abstract
[This retracts the article DOI: 10.3389/fonc.2023.1137913.].
Copyright © 2024 Frontiers Editorial Office.
Retraction of
-
Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis.Front Oncol. 2023 Apr 19;13:1137913. doi: 10.3389/fonc.2023.1137913. eCollection 2023. Front Oncol. 2023. Retraction in: Front Oncol. 2024 Feb 19;14:1383366. doi: 10.3389/fonc.2024.1383366. PMID: 37152014 Free PMC article. Retracted.
Similar articles
-
Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis.Front Oncol. 2023 Apr 19;13:1137913. doi: 10.3389/fonc.2023.1137913. eCollection 2023. Front Oncol. 2023. Retraction in: Front Oncol. 2024 Feb 19;14:1383366. doi: 10.3389/fonc.2024.1383366. PMID: 37152014 Free PMC article. Retracted.
-
Retraction: Meta analysis of clinical prognosis of radiofrequency ablation versus partial nephrectomy in the treatment of early renal cell carcinoma.Front Oncol. 2024 Feb 20;14:1383353. doi: 10.3389/fonc.2024.1383353. eCollection 2024. Front Oncol. 2024. PMID: 38444681 Free PMC article.
-
Retraction: Effects of Aidi injection on life quality and incidence of adverse reactions in patients with non-small cell lung cancer compared with traditional chemotherapy: a systematic review and meta-analysis.Front Oncol. 2024 Feb 19;14:1383346. doi: 10.3389/fonc.2024.1383346. eCollection 2024. Front Oncol. 2024. PMID: 38440226 Free PMC article.
-
Corrigendum: Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma.Front Oncol. 2021 Dec 30;11:836903. doi: 10.3389/fonc.2021.836903. eCollection 2021. Front Oncol. 2021. PMID: 35036356 Free PMC article.
-
Safety and Efficacy of PD-1/PD-L1 inhibitors combined with radiotherapy in patients with non-small-cell lung cancer: a systematic review and meta-analysis.Cancer Med. 2021 Feb;10(4):1222-1239. doi: 10.1002/cam4.3718. Epub 2021 Jan 19. Cancer Med. 2021. PMID: 33465302 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials